We reach the last days of the year and it is a good time to look back and recognize all the work of the team and collaborators, who have made it possible to achieve important achievements.
The path towards the universalization of precision surgery involves moving forward with a firm and confident step, obtaining the necessary certifications and authorizations, demonstrating the reliability of the Bitrack system.
A year of success
Presence at the Mobile World Congress 2023 (MWC23), which is the first opportunity to see and perform simulations of abdominal operations with the robot and the technological platform.
Rob Surgical receives authorization to conduct clinical trials.
We completed the first series of operations on patients in collaboration with the Hospital Clínic of Barcelona. The nephrectomies performed by the Clínic Urology Service team with the surgical robot are carried out satisfactorily without any adverse events.
Todd Usen joins the Rob Surgical team to lead the Board of Directors.
We shared the evolution of the Rob Surgical project at the Emerging Medtech Summit LSI Europe ’23, the most influential event in the world in the MedTech sector.
Todd Usen visits the Rob Surgical facilities in Barcelona and attends an intervention with the Bitrack robot.
We extend the collaboration agreement with the Hospital Clínic of Barcelona and begin a new series of interventions with patients. The achievement of these operations allows us to continue advancing and expanding the scope of usefulness of the Bitrack robot, with the aim of covering all the needs of Urology and extending its use to other specialties.
The second series of interventions is carried out with patients at the Hospital Clínic of Barcelona.
It has been a year of great success that has taken us to the starting point of the production of robotic units at our facilities in El Prat de Llobregat. We continue working to reach the next goal: 50 units installed in European hospitals by 2025.
